Millennium Research Group (MRG), the global authority on medical technology market intelligence, has conducted a detailed and thorough analysis of the US critical care patient monitoring market and finds that neonatal electroencephalography (EEG) monitoring is being used to detect brain damage in infants. Physicians can detect seizures and cerebral abnormalities with these systems, allowing them to identify developmental problems in neonates at an early stage. Part of a two-report series covering U.S. and Europe, U.S. Markets for Critical Care Patient Monitoring Devices reports that over the next five years, the market will continue to grow, driven in part by increased clinical support for new patient monitoring technologies.

Neonatal EEG is useful for identifying infants with a serious condition known as hypoxic-ischemic encephalopathy (HIE), which is characterized by acute brain injury due to deprivation of oxygen and blood flow to the brain. Often, the underlying cause of the brain injury and the exact time it occurred are uncertain. In the past, the value of neonatal EEG monitoring was limited because there was no effective treatment for the abnormalities detected; however, a new technique called therapeutic hypothermia has been proven to be useful for mild to moderate cases of HIE.

"There remains considerable debate about therapeutic hypothermia," says David Plow, senior analyst at MRG. "Issues still under investigation include how best to administer the treatment, the safety of the procedure, and whole- body versus head cooling. Nevertheless, some studies show promising results. If widespread adoption of infant cooling occurs, it may become a significant driver of growth for neonatal EEG monitoring."

U.S. Markets for Critical Care Patient Monitoring Devices 2007 is one of two new critical care reports by MRG-European Markets for Critical Care Patient Monitoring Devices 2007 will soon be available. These reports include coverage of key industry competitors, including Philips Medical Systems (PHI), GE Healthcare (GE), Spacelabs Medical (SLAB), Datascope (DSCP), Edwards Lifesciences (EW), Welch Allyn, Nihon Kohden, Drager Medical (a joint venture between Dragerwerk [DRW3] and Siemens Medical Solutions [SIE]), Integra LifeSciences (IART), Somanetics (SMTS), Hospira (HSP), Respironics (RESP), and Codman & Shurtleff (A Johnson & Johnson Company (JNJ).

About Therapeutic Hypothermia

Therapeutic Hypothermia involves reducing brain temperature by 3° to 4°C which reduces the swelling of the brain, thereby decreasing the extent of brain injury.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResources.com), is a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

  All company, brand, or product names contained in this document may be      trademarks or registered trademarks of their respective holders.     For more information, contact:    Amy Krohn    Millennium Research Group    416-364-7776 x101    akrohn@mrg.net 

SOURCE: Millennium Research Group

CONTACT: Amy Krohn of Millennium Research Group, +1-416-364-7776 x101,
akrohn@mrg.net

While Some Physicians Believe That Inhaled Corticosteroids are Overused for the Treatment of Chronic Obstructive Pulmonary Disease, Majority Say the Drugs Help Treat the Disease

View Now